Using MRI scans to guide treatment of blocked leg arteries
Studies MRI scans of artery plaque in people with peripheral arterial disease.
Key facts
- Who runs it
- The Methodist Hospital Research Institute
- Where
- Houston, United StatesSee the site
- Trial code
- Registry title
- MRI Guided Management of Occlusive Peripheral Arterial Disease
- Status
- Recruiting
- People taking part
- 175 people, planned
- Started
- 1 Jul 2024
- Expected to end
- Jun 2029
- Type of study
- Observational, 2 groups
- Record updated
- 19 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral arterial disease (narrowed leg arteries) who are having a planned procedure to open the arteries, or a leg amputation. An MRI scan will look at the plaque in the artery.
- Age
- 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- Peripheral arterial disease, Rutherford Category 4, 5 or 6 (pain at rest, sores or tissue loss). At least 1 narrowed spot below the knee in the person's own arteries, in one or both legs. The narrowing must be more than 50%, in an artery 2.0 - 4.0 mm wide.
Main reasons for not taking part
- Rutherford category 0, 1, 2 or 3 in the leg being studied.
- Not able to have an MRI scan.
- Not giving written consent.
- For the amputation part (Aim 2) only: arteries that are fully blocked for a long time (chronic total occlusions).
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- General Inclusion Criteria:
- All patients will be ≥ 18 years old with PAD (Rutherford Category 4, 5, 6)
- Anatomic inclusion criteria:
- At least 1 target lesion below-the-knee in native vessels in one or both limbs ii. Target lesion reference vessel diameter between 2.0 - 4.0 mm by investigator visual estimate iii. Target lesion with > 50% stenosis by investigator visual estimate
Who cannot take part
- Rutherford category 0, 1, 2, 3 of target limb, Failure or refusal to provide written informed consent, MRI Contraindications
- General Exclusion Criteria:
- Anatomic Exclusion Criteria:
- Aim 2 only - Chronic total occlusions
Where in United States
- Houston Methodist HospitalHouston, United StatesContact: Trisha Roy, MD, PhDTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize vessel wall injury.
Read full original descriptionShow less
Patients undergoing intervention will have an MRI scan prior to their planned percutaneous vascular intervention to assess the plaque and predict procedural difficulty.
Patients undergoing lower limb amputation due to peripheral arterial disease will have their limbs included into a second arm of the study The limb will undergo an MRI scan to assess the plaque. The investigator will then test two different devices and assess the effects of these devices on the vessel wall.
The 2 groups in the trial
- Amputation Arm
In an ex vivo human cadaveric model, post-PVI histopathologic analysis will be used to uncover the impact of plaque type on device safety (POBA versus atherectomy) and performance, facilitating evidence-based device selection to mitigate complications. Using a randomized approach, the investigator will compare plain balloon angioplasty to orbital atherectomy prior to angioplasty in amputated legs from PAD patients with plaques characterized into 4 categories based their MRI-histology: concentric calcium, eccentric calcium, fibrous plaque, and soft plaques (smooth muscle and thrombus).
- Revascularization Arm
Patient Imaging Protocol: Scans will be performed on 100 patients enrolled into the study population using a 3T MAGNETOM scanner (Siemens) at the Houston Methodist Research Institute Translational Imaging Center. The investigator will use pre-operative images captured using the optimized MRI-histology sequences to score lesions. Physicians performing PVI will be blinded to the pre-operative MRI-histology images and anatomic scores and will make treatment decisions based on their standard of care. The investigator expect MRI-histology plaque scores predict which patients will have PVI failures due to untraversable plaque, and it may also foresee the potential need of adjunctive devices or alternative approaches for successful PVI
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MRI Guided Management of Occlusive Peripheral Arterial Disease
- Plain-language title
- Using MRI scans to guide treatment of blocked leg arteriesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 19 March 2026